Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Multi-center, Randomized, Double Blinded, Active-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis

Multi-center, Randomized, Double Blinded, Active-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of SKCPT in Patients with knee Osteoarthritis

Inclusion Criteria:

• Adult males and females aged 20 to 75 years
• Kellgren-Lawrence (KL) grade 1 to 3
• Individuals who voluntarily decide to participate in the study and provide written informed consent form
• Individuals who can understand and follow instructions and can participate in the study during the entire study period

Exclusion Criteria:

• Individuals who have clear secondary osteoarthritis caused by inflammatory, infectious, metabolic arthritis, or other conditions such as rheumatoid arthritis, rather than primary knee osteoarthritis as determined by the investigator
• Individuals with other factors that could potentially affect the assessment of this clinical study due to pain caused by osteoarthritis or other conditions in the hip joint
• Individuals who have undergone knee joint arthroplasty
• Individuals who have undergone open knee surgery (ligament reconstruction, osteotomy) within 3 years prior to the screening visit